Blueprint Medicines Corp (BPMC) Insider Trading
- $348,278.00
- $177,560,027.15
- March 24, 2025
- Jeffrey W Albers
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 6, 2023 | CEO | 6,640 | $45.69 | Sell | $303,381.60 | |
March 6, 2023 | Director | 9,793 | $45.67 | Sell | $447,246.31 | |
Dec. 5, 2022 | Director | 20,000 | $50.09 | Sell | $1,001,800.00 | |
Nov. 3, 2022 | COO | 533 | $45.24 | Sell | $24,112.92 | |
Nov. 3, 2022 | CEO | 1,100 | $43.98 | Buy | $48,378.00 | |
Oct. 4, 2022 | Insider | 3,477 | $67.30 | Sell | $234,002.10 | |
Aug. 24, 2022 | Insider | 5,000 | $75.11 | Sell | $375,550.00 | |
Aug. 22, 2022 | Director | 8,410 | $70.54 | Sell | $593,241.40 | |
Aug. 19, 2022 | Director | 1,590 | $70.02 | Sell | $111,331.80 | |
Aug. 16, 2022 | Director | 20,000 | $68.41 | Sell | $1,368,200.00 | |
Aug. 8, 2022 | Director | 10,000 | $70.07 | Sell | $700,700.00 | |
Aug. 4, 2022 | SVP | 2,500 | $60.44 | Sell | $151,100.00 | |
June 6, 2022 | Insider | 1,908 | $59.76 | Sell | $114,022.08 | |
April 6, 2022 | CEO | 5,000 | $70.11 | Sell | $350,550.00 | |
March 16, 2022 | Insider | 2,219 | $60.00 | Sell | $133,140.00 | |
March 10, 2022 | Insider | 2,339 | $57.15 | Sell | $133,673.85 | |
March 7, 2022 | Insider | 256 | $56.19 | Sell | $14,384.64 | |
March 3, 2022 | Insider | 761 | $60.27 | Sell | $45,865.47 | |
March 3, 2022 | Director | 5,000 | $59.98 | Buy | $299,900.00 | |
Dec. 15, 2021 | Insider | 729 | $100.00 | Sell | $72,900.00 | |
Dec. 13, 2021 | COO | 1,000 | $98.30 | Sell | $98,300.00 | |
Dec. 7, 2021 | EVP | 5,000 | $97.30 | Sell | $486,500.00 | |
Nov. 15, 2021 | CEO | 30,000 | $114.50 | Sell | $3,435,000.00 | |
Nov. 15, 2021 | Insider | 729 | $115.49 | Sell | $84,192.21 | |
Nov. 3, 2021 | EVP | 5,000 | $110.56 | Sell | $552,800.00 | |
Oct. 15, 2021 | Insider | 729 | $102.66 | Sell | $74,839.14 | |
Oct. 5, 2021 | Insider | 3,241 | $98.18 | Sell | $318,201.38 | |
Sept. 23, 2021 | EVP | 25,000 | $108.85 | Sell | $2,721,250.00 | |
Sept. 23, 2021 | Insider | 600 | $110.00 | Sell | $66,000.00 | |
Aug. 19, 2021 | CEO | 25,000 | $92.68 | Sell | $2,317,000.00 | |
Aug. 17, 2021 | Insider | 1,350 | $91.93 | Sell | $124,105.50 | |
June 28, 2021 | COO | 1,000 | $90.24 | Sell | $90,240.00 | |
May 12, 2021 | CEO | 25,000 | $92.69 | Sell | $2,317,250.00 | |
Jan. 4, 2021 | Director | 758 | $112.15 | Sell | $85,009.70 | |
Dec. 24, 2020 | Director | 5,455 | $125.00 | Sell | $681,875.00 | |
Dec. 17, 2020 | Director | 10,909 | $117.82 | Sell | $1,285,298.38 | |
Dec. 1, 2020 | Director | 5,454 | $110.00 | Sell | $599,940.00 | |
Nov. 3, 2020 | Insider | 345 | $99.69 | Sell | $34,393.05 | |
Oct. 16, 2020 | COO | 13,334 | $101.23 | Sell | $1,349,800.82 | |
Oct. 7, 2020 | Director | 5,454 | $100.00 | Sell | $545,400.00 | |
Oct. 7, 2020 | Insider | 600 | $100.00 | Sell | $60,000.00 | |
Oct. 7, 2020 | CEO | 5,000 | $99.17 | Sell | $495,850.00 | |
Sept. 22, 2020 | Director | 1,704 | $85.00 | Sell | $144,840.00 | |
Sept. 22, 2020 | Insider | 6,864 | $82.33 | Sell | $565,113.12 | |
Sept. 22, 2020 | COO | 3,143 | $85.49 | Sell | $268,695.07 | |
Sept. 17, 2020 | Director | 500 | $80.00 | Sell | $40,000.00 | |
Sept. 17, 2020 | Insider | 23,136 | $80.00 | Sell | $1,850,880.00 | |
Aug. 17, 2020 | Insider | 700 | $75.00 | Sell | $52,500.00 | |
July 6, 2020 | Director | 26,007 | $80.45 | Sell | $2,092,263.15 | |
July 2, 2020 | Director | 4,125 | $80.16 | Sell | $330,660.00 |
Insiders are both buying and selling Blueprint Medicines Corp stock.
The insider traders at Blueprint Medicines Corp are: Jeffrey W Albers, Ariel Hurley, Kate Haviland, Christina Rossi, Daniel Lynch, L. Becker Hewes, Christopher K Murray, George Demetri, Nicholas Lydon, Marion Dorsch, Debra Durso-Bumpus, Anthony L Boral, Tracey L Mccain, Fmr Llc, Michael Landsittel, Christoph Lengauer, Mark Alan Goldberg, Fouad Namouni, Percy H Carter, Charles A Rowland Jr, Rock Ventures Ii L.P. Third, Kevin P. Starr, Lonnel Coats, Mark J Levin, Alexis Borisy, and Philina Lee
The most active insider trader at Blueprint Medicines Corp is Jeffrey W Albers with 41 trades.
Rock Ventures Ii L.P. Third has sold the most Blueprint Medicines Corp stock with a total value of $70,560,000.00.
Mark Alan Goldberg has bought the most Blueprint Medicines Corp stock with a total value of $599,800.00.
The most recent insider trade for Blueprint Medicines Corp was on March 24, 2025.
The single biggest insider buy for Blueprint Medicines Corp was from Mark Alan Goldberg with a total value of $299,900.00 on March 3, 2022.
The single biggest insider sell for Blueprint Medicines Corp was from Rock Ventures Ii L.P. Third with a total value of $35,280,000.00 on Feb. 7, 2017.